CITADEL ADVISORS LLC 13D and 13G filings for OnKure Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-11 5:24 pm Purchase |
2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR |
CITADEL ADVISORS LLC | 1,271,371 9.900% |
1,271,371 (New Position) |
Filing |